TNF and breast cancer: Among the iNOS+ (R1 gate) and TNF-α+ (R2 gate) LN cells, resistant B6.WT mice displayed ∼10-fold and ∼3-fold more CD11bhi CD11chi cells compared to susceptible BC.WT mice, respectively (Figure 1B).